Highnoon Laboratories Ltd
Romesh Elapata is the current Director at Highnoon Laboratories Ltd. Prior to this, they worked as the Head of Accounts at Varioline Services from January 2016 to November 2017. Romesh has also worked as the Assistant Manager Accounts & Taxation at Varioline Intercool Pakistan Private Limited from March 2015 to December 2015. Romesh Elapata started their career as a Senior Auditor at EY in June 2011 and worked there till March 2015.
Romesh Elapata is a Chartered Accountant from the Institute of Chartered Accountants of Pakistan. Romesh has also done their Intermediate from Government College University, Lahore. Romesh has got certification from The Professional's Academy of Commerce in Computer Course Practical Training, from Pakistan Institute of Management in Dashboard Reporting and Advance MS Excel and from The Institute of Chartered Accountants of Pakistan in Certificate Course on Data Analysis and Visualization using Power BI.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Highnoon Laboratories Ltd
Highnoon Laboratories Limited is a Pakistan-based pharmaceutical company. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products. The Company offers products for various therapeutic areas, such as alimentary tract and metabolism, cardiovascular and respiratory products. The Company's product brands for alimentary tract and metabolism include Tres Orix Forte, Ulsanic, Skilax and Tagipmet. The Company's cardiovascular portfolio includes Misar brand, which is an angiotensin receptor blocker (ARB) used in the management of hypertension. Its products include AIRTAL (Aceclofenac), which has non-steroidal, anti-inflammatory and analgesic properties; ARIA (ketotifen), a non-bronchodilator antiasthamatic drug; ARTECXCIN, which acts as a blood schizotocide, and artrodar (diacerein), used for the treatment of inflammation and rheumatism. Its other products include Asthavent, AXESOME, Bezisox and Betatec.